Federal Cuts to National Institutes of Health Would Threaten New Drug Development and Innovation
A new report from the nonpartisan Congressional Budget Office (CBO) finds that proposed cuts at the National Institutes of Health (NIH) could lower the number of new drugs that come to market in the next three decades.